FMC (FMC) Q3 2026 Earnings Call Transcript

FMC reported Q3 2026 earnings, including a $672M EBITDA impact from commercial actions. Revenue was $106M, with underlying sales at $745M, below guidance. Adjusted EBITDA was negative $559M. The company is changing its North America business model and adjusting prices to reduce channel inventory. Q4 revenue is expected to be $1.04B-$1.14B, with adjusted EBITDA between $210M-$230M.

Original reporting
Published Oct 30, 2026, 7:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FMC (FMC) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$FMCBearishHigh
01

Why it matters

The earnings release introduces new material numbers and guidance, likely prompting a sell‑off.

02

Market read

The disclosed charge and guidance downgrade are fresh, material information that can affect FMC's stock price immediately.

03

What to watch

Potential cost reductions from manufacturing footprint changes and new product launches may offset short‑term pain.

Relevance 8/10Novelty 8/10Timing: after-hours today

Background

FMC reported Q3 2026 results with a large non‑cash charge related to inventory pricing adjustments and provided lowered Q4 guidance.

Company-level read

Ticker impact

$FMCBearishHigh confidence
Context

Q3 2026 earnings call disclosed a $672M EBITDA impact from commercial actions and lowered Q4 guidance.

Expected impact

likely downward pressure as investors price in the $672M charge and reduced Q4 outlook

Evidence & confidence

The disclosed charge and guidance downgrade are fresh, material information that can move the stock immediately.

Market effects

Agricultural chemicals sector may see broader concerns over pricing models and inventory pressures.

North America growers could face higher input costs, affecting regional ag‑input demand.

FMC's pricing changes could influence global ag‑chemical pricing dynamics.

Counterpoint

If the inventory adjustments succeed, future quarters could see improved margins and a rebound.

Key entities

  • FMC Corporation

    US‑listed agricultural chemicals producer.

Related articles

$FMCHigh

KeyBanc downgrades FMC stock rating on turnaround concerns

KeyBanc downgraded FMC Corp. (NYSE:FMC) to Sector Weight, citing risks to its turnaround efforts. The stock, at $5.21, has fallen 61.5% in a year. KeyBanc set a fair value of $5.50, while InvestingPro's analysis suggests a Fair Value of $6.36. FMC plans to raise $1 billion, including $400 million in equity, and anticipates a return to growth in 2027. Jefferies initiated coverage with a Hold rating and a $6.00 price target.

$FMCMed

Fresenius Medical cuts top end of 2026 profit outlook

Fresenius Medical Care adjusted its 2026 operating income outlook, now expecting a flat to mid-single-digit percentage decline, down from a previous range of decline to increase. Q3 operating income fell 5% to €545 million, while revenue grew 1% to €4.94 billion. US same-market treatments declined 1.1%. The company faces regulatory and inflation challenges under new CEO Shervin J. Korangy.

$FMCHighAI 8/10

Why FMC Corporation Rallied Today

FMC Corporation (NYSE:FMC) shares surged 30.4% after Q3 earnings, despite an 80% revenue drop to $106M and a loss of $4.41 per share. The decline was partly due to one-time price cuts and accounting adjustments. Management guided Q4 revenue to $1.11B and positive EBITDA of $220M, with expectations of $650M EBITDA in 2024 and $760M in 2028.

$FMCHighAI 9/10

FMC Q3 Earnings Call Highlights

FMC reported Q3 revenue of $1.06B, including $639M from commercial actions, and adjusted EBITDA of -$559M. Q4 outlook was lowered, with revenue expected at $1.04B-$1.14B and adjusted EBITDA at $210M-$230M. FMC cited market challenges and pricing headwinds. The company expects full-year free cash flow to be -$350M to -$150M, including restructuring spending. FMC also announced preliminary 2027 and 2028 adjusted EBITDA targets of $650M-$730M and $760M-$840M, respectively.

$FMCHighAI 9/10

Why is FMC stock surging today?

FMC Corporation (FMC) stock rose 23.6% after reporting a Q3 2026 loss of $2.07 billion, largely due to a $639 million restructuring charge. Investors focused on improved cash flow and management's multi-year recovery outlook, with Q4 revenue guidance of $1.04B-$1.14B. Barclays maintained a Sell rating with a $4.00 target. The broader market declined, but FMC's rally was driven by short covering and relief.